<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>) is a dominant <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorder</z:e> caused by an expansion of the polyglutamine tract in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>-1 gene product, ataxin-3 </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, studies show that phosphorylation of polyglutamine disease proteins, such as huntingtin, ataxin-1 and DRPLA, plays an important role in regulating pathogenesis </plain></SENT>
<SENT sid="2" pm="."><plain>However, the kinase that phosphorylates ataxin-3 remains unknown </plain></SENT>
<SENT sid="3" pm="."><plain>Here we show that S256 site in ataxin-3 is phosphorylated by GSK 3beta </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, S256A mutant of expanded ataxin-3 forms high molecular weight protein aggregation, whereas S256D mutant and expanded ataxin-3 without mutation on this site are monomeric </plain></SENT>
<SENT sid="5" pm="."><plain>The molecular chaperone Hsp70 represses the aggregation of S256A mutant </plain></SENT>
<SENT sid="6" pm="."><plain>Our results imply that phosphorylation of serine 256 in ataxin-3 by GSK 3beta regulates ataxin-3 aggregation </plain></SENT>
</text></document>